Neumora director granted 80,000 stock options
Neumora Therapeutics, Inc. director and 10% owner Kristina Burow received a grant of stock options covering 80,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Neumora Therapeutics, Inc. director and 10% owner Kristina Burow received a grant of stock options covering 80,000 shares of common stock. The options have an exercise price of $1.86 per share and expire on May 26, 2036.
According to the grant terms, 100% of the shares subject to the option vest on the earlier of the one-year anniversary of May 27, 2026 or immediately before the next annual meeting following that date. After this grant, the filing shows 80,000 derivative securities held directly.
Insider Trade Summary
Grant/Award: 80,000 shares
Grant/Award
1 txn
Insider
Burow Kristina
Role
Director, 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 80,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 80,000 contracts (Direct)
Footnotes (1)
- F1. 100% of the shares subject to the option vest on the earlier of (i) the one year anniversary of May 27, 2026 or (ii) immediately prior to the next Annual Meeting following May 27, 2026.
Key Figures
Options granted: 80,000 options
Exercise price: $1.86 per share
Expiration date: May 26, 2036
+2 more
5 metrics
Options granted
80,000 options
Stock Option (Right to Buy) grant to director and 10% owner
Exercise price
$1.86 per share
Conversion or exercise price for the stock options
Expiration date
May 26, 2036
Option term end date for the granted stock options
Underlying shares
80,000 shares
Common stock underlying the granted stock options
Holdings after grant
80,000 derivative securities
Total options held directly after the transaction
Key Terms
Stock Option (Right to Buy), exercise price, vesting, Annual Meeting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 1.8600"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"100% of the shares subject to the option vest on the earlier of"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Annual Meeting financial
"immediately prior to the next Annual Meeting following May 27, 2026"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Neumora Therapeutics (NMRA) report for Kristina Burow?
Neumora reported that director and 10% owner Kristina Burow received a grant of stock options for 80,000 shares of common stock. These options are a compensation-related award, not an open-market purchase or sale of existing shares.
What are the key terms of the 80,000 Neumora (NMRA) stock options granted to Kristina Burow?
The granted options cover 80,000 shares of Neumora common stock at an exercise price of $1.86 per share. They expire on May 26, 2036, giving a long exercise window typical for equity compensation.
When do Kristina Burow’s Neumora (NMRA) stock options vest?
All 80,000 options vest 100% on the earlier of the one-year anniversary of May 27, 2026 or immediately before the next annual meeting after that date. This creates a single vesting event rather than gradual vesting.
Is Kristina Burow’s Neumora (NMRA) Form 4 transaction a buy or a grant?
The Form 4 shows a grant/award acquisition, coded “A,” of stock options, not an open-market buy. The company awarded options with an exercise price of $1.86, so no cash changed hands at grant time.
How many Neumora (NMRA) derivative securities does Kristina Burow hold after this Form 4?
Following the reported transaction, the filing indicates that Kristina Burow directly holds 80,000 derivative securities in the form of stock options. These options are exercisable into an equal number of shares of Neumora common stock once vested.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates